Genetic Background Influences Severity of Colonic Aganglionosis and Response to GDNF Enemas in the Holstein Mouse Model of Hirschsprung Disease

Int J Mol Sci. 2021 Dec 5;22(23):13140. doi: 10.3390/ijms222313140.

Abstract

Hirschsprung disease is a congenital malformation where ganglia of the neural crest-derived enteric nervous system are missing over varying lengths of the distal gastrointestinal tract. This complex genetic condition involves both rare and common variants in dozens of genes, many of which have been functionally validated in animal models. Modifier loci present in the genetic background are also believed to influence disease penetrance and severity, but this has not been frequently tested in animal models. Here, we addressed this question using Holstein mice in which aganglionosis is due to excessive deposition of collagen VI around the developing enteric nervous system, thereby allowing us to model trisomy 21-associated Hirschsprung disease. We also asked whether the genetic background might influence the response of Holstein mice to GDNF enemas, which we recently showed to have regenerative properties for the missing enteric nervous system. Compared to Holstein mice in their original FVB/N genetic background, Holstein mice maintained in a C57BL/6N background were found to have a less severe enteric nervous system defect and to be more responsive to GDNF enemas. This change of genetic background had a positive impact on the enteric nervous system only, leaving the neural crest-related pigmentation phenotype of Holstein mice unaffected. Taken together with other similar studies, these results are thus consistent with the notion that the enteric nervous system is more sensitive to genetic background changes than other neural crest derivatives.

Keywords: GDNF; Hirschsprung disease; enteric nervous system; genetic background; melanocytes; mouse model; neural crest; pigmentation; regenerative medicine; tissue-resident stem cells.

MeSH terms

  • Animals
  • Collagen Type VI / genetics*
  • Disease Models, Animal
  • Enema
  • Glial Cell Line-Derived Neurotrophic Factor / administration & dosage*
  • Glial Cell Line-Derived Neurotrophic Factor / pharmacology
  • Hirschsprung Disease / drug therapy*
  • Hirschsprung Disease / genetics*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Regenerative Medicine
  • Treatment Outcome

Substances

  • Collagen Type VI
  • Glial Cell Line-Derived Neurotrophic Factor